Atlas Trials

Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects

Clinical trial NCT02498652 · COMPLETED

Trial details

NCT number
NCT02498652
Sponsor
Ardea Biosciences, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gout
Start date
2015-07-28
Primary completion
2015-11-19
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.